HUM three-lens brief
Evidence-based stock research on HUM. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 57.3pp over 30 days. · RSI at 88 — technically overbought.
- RSI at 88 — technically overbought.
- Outperforming SPY by 57.3pp over 30 days.
- Analyst mean target $243.71 — 18% below current (24 analysts).
- Debt-to-equity of 77.1 — balance-sheet-heavy.
HUM closed at $295.83 (+0.16%) as of 2026-05-13. Market cap: $35.52B. P/E (trailing) 31.6. Positives: outperforming SPY by 57.3pp over 30 days.. Concerns: rSI at 88 — technically overbought.; analyst mean target $243.71 — 18% below current (24 analysts).. Last quarter: Revenue $39.65B, net income $1.19B, free cash flow $1.43B.
Why three lenses on HUM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine HUMacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/HUM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath HUM brief"></iframe>